ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 85 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $323,000 | -86.3% | 19,100 | -86.7% | 0.21% | -73.6% |
| Q3 2016 | $2,365,000 | +25.0% | 144,100 | +15.3% | 0.81% | +6.5% |
| Q2 2016 | $1,892,000 | +4.7% | 125,000 | 0.0% | 0.76% | +0.9% |
| Q1 2016 | $1,807,000 | -49.0% | 125,000 | 0.0% | 0.75% | -24.7% |
| Q4 2015 | $3,540,000 | -6.0% | 125,000 | -44.4% | 1.00% | +38.3% |
| Q3 2015 | $3,766,000 | -36.2% | 225,000 | 0.0% | 0.72% | +29.5% |
| Q2 2015 | $5,899,000 | +49.9% | 225,000 | 0.0% | 0.56% | +49.5% |
| Q1 2015 | $3,935,000 | +0.7% | 225,000 | 0.0% | 0.37% | -0.8% |
| Q4 2014 | $3,908,000 | -6.7% | 225,000 | 0.0% | 0.38% | -13.2% |
| Q3 2014 | $4,189,000 | +1.8% | 225,000 | 0.0% | 0.43% | +22.4% |
| Q2 2014 | $4,113,000 | – | 225,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
| Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
| DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
| Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
| Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
| Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
| Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
| EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |